Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2071 to 2085 of 9034 results

  1. Filgotinib for treating axial spondyloarthritis [ID6594]

    In development Reference number: GID-TA11776 Expected publication date: TBC

  2. Setmelanotide for treating acquired hypothalamic obesity in people 4 years and over [ID6542]

    In development Reference number: GID-TA11525 Expected publication date:  10 February 2027

  3. Denecimig (Mim8) for preventing bleeding episodes in haemophilia A in people of any age [ID6400]

    In development Reference number: GID-TA11509 Expected publication date:  24 February 2027

  4. Anitocabtagene autoleucel for treating relapsed or refractory multiple myeloma ID6549

    Topic prioritisation

  5. Cryoablation for Desmoid-type Fibromatosis

    Topic prioritisation

  6. MRI-guided laser interstitial thermal therapy for early prostate cancer

    Topic prioritisation

  7. Transcatheter Tricuspid Valve Replacement

    Topic prioritisation

  8. Infrared lasers for treating onychomycosis

    Topic prioritisation

  9. Spirecut's Sono-Instruments to treat carpal tunnel syndrome and trigger finger

    Topic prioritisation

  10. Percutaneous intraductal radiofrequency ablation for malignant biliary obstruction

    Topic prioritisation

  11. Laparoscopic lumbar sympathectomy for foot hyperhidrosis

    Topic prioritisation

  12. External stimulation of the auricular branch of the vagus nerve

    Topic prioritisation

  13. Percutaneous transluminal radiofrequency sympathetic denervation of the renal artery for glycemic control

    Topic prioritisation

  14. Tucatinib with trastuzumab emtansine for treating HER2-positive unresectable or advanced breast cancer after a taxane, trastuzumab or both together [ID6165]

    Awaiting development Reference number: GID-TA11110 Expected publication date: TBC

  15. Benegrastim for treating chemotherapy-induced neutropenia in people with breast cancer [TSID11769]

    Awaiting development Reference number: GID-TA11088 Expected publication date: TBC